Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Gallegos LL"'
Autor:
Antal, CE, Hudson, AM, Kang, E, Zanca, C, Wirth, C, Stephenson, NL, Trotter, EW, Gallegos, LL, Miller, CJ, Furnari, FB, Hunter, T, Brognard, J, Newton, AC
Publikováno v:
Antal, CE; Hudson, AM; Kang, E; Zanca, C; Wirth, C; Stephenson, NL; et al.(2015). Cancer-associated protein kinase C mutations reveal kinase's role as tumor suppressor. Cell, 160(3), 489-502. doi: 10.1016/j.cell.2015.01.001. UC Davis: Retrieved from: http://www.escholarship.org/uc/item/5903j9zb
© 2015 Elsevier Inc.Protein kinase C (PKC) isozymes have remained elusive cancer targets despite the unambiguous tumor promoting function of their potent ligands, phorbol esters, and the prevalence of their mutations. We analyzed 8% of PKC mutations
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::3d908200df73f2a9f11a55b6aae0502c
http://www.escholarship.org/uc/item/5903j9zb
http://www.escholarship.org/uc/item/5903j9zb
Autor:
Aleman Cruz, Edgar Hipolito, Aliaga Viera, Segundo Eleazar, Barreto Brandt, Roman, Bocanegra Jesus, Alejandra Isabel, Gallegos Llerena, Cesar Arnaldo, Jáuregui Farfán, Jorge Jesús, Montellanos Cabrera, Henry Sam, Pinedo Pichilingue, Andrea Aranza
Publikováno v:
Universidad Peruana de Ciencias Aplicadas (UPC)Repositorio Académico - UPC.
El curso revisa desde una visión integral, el desarrollo, estructura, función y disfunción de la sangre y órganos hematopoyéticos. Las actividades de aprendizaje están diseñadas para que los estudiantes utilicen los conocimientos en sus explic
Externí odkaz:
http://hdl.handle.net/10757/627908
Publikováno v:
Universidad Peruana de Ciencias Aplicadas (UPC)Repositorio Académico - UPC.
Ante la problemática del déficit de viviendas en la sierra sur del Perú y la baja rentabilidad de las constructoras en este tipo de proyectos, el presente trabajo de investigación busca mejorar la rentabilidad en proyectos de vivienda social en l
Externí odkaz:
http://hdl.handle.net/10757/624662
Autor:
Gallegos LL; Roche Diagnostics, Tucson, AZ 85755, USA., Gilchrist A; Royal Marsden NHS Foundation Trust, London, UK., Spain L; Royal Marsden NHS Foundation Trust, London, UK.; Francis Crick Institute, London, UK., Stanislaw S; Roche Diagnostics, Tucson, AZ 85755, USA., Hill SM; Roche Diagnostics, Tucson, AZ 85755, USA., Primus V; Royal Marsden NHS Foundation Trust, London, UK., Jones C; Roche Diagnostics, Tucson, AZ 85755, USA., Agrawal S; Royal Marsden NHS Foundation Trust, London, UK., Tippu Z; Royal Marsden NHS Foundation Trust, London, UK.; Francis Crick Institute, London, UK., Barhoumi A; Roche Diagnostics, Tucson, AZ 85755, USA., Noel-Storr G; Royal Marsden NHS Foundation Trust, London, UK., Alexander NR; Roche Diagnostics, Tucson, AZ 85755, USA., Turajlic S; Royal Marsden NHS Foundation Trust, London, UK.; Francis Crick Institute, London, UK.
Publikováno v:
STAR protocols [STAR Protoc] 2021 Jun 26; Vol. 2 (3), pp. 100624. Date of Electronic Publication: 2021 Jun 26 (Print Publication: 2021).
Autor:
Litchfield K; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK., Stanislaw S; Roche Tissue Diagnostics, 1910 E. Innovation Park Drive, Tucson, AZ 85755, USA., Spain L; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK; Renal and Skin Units, The Royal Marsden Hospital, London SW3 6JJ, UK., Gallegos LL; Roche Tissue Diagnostics, 1910 E. Innovation Park Drive, Tucson, AZ 85755, USA., Rowan A; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK., Schnidrig D; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK., Rosenbaum H; Roche Sequencing Solutions, Madison, 500 S. Rosa Road, Madison, WI 53719, USA., Harle A; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK; Université de Lorraine, CNRS UMR 7039 CRAN, Institut de Cancérologie de Lorraine, Service de Biopathologie, 54000 Nancy, France., Au L; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK; Renal and Skin Units, The Royal Marsden Hospital, London SW3 6JJ, UK., Hill SM; Roche Tissue Diagnostics, 1910 E. Innovation Park Drive, Tucson, AZ 85755, USA; Department of Cancer Biology, University of Arizona Cancer Center, Tucson, AZ 85724, USA., Tippu Z; Renal and Skin Units, The Royal Marsden Hospital, London SW3 6JJ, UK., Thomas J; Renal and Skin Units, The Royal Marsden Hospital, London SW3 6JJ, UK., Thompson L; The Centre for Molecular Pathology, The Royal Marsden Hospital, London SW3 6JJ, UK., Xu H; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK., Horswell S; Department of Bioinformatics and Biostatistics, The Francis Crick Institute, London NW1 1AT, UK., Barhoumi A; Roche Tissue Diagnostics, 1910 E. Innovation Park Drive, Tucson, AZ 85755, USA., Jones C; Roche Tissue Diagnostics, 1910 E. Innovation Park Drive, Tucson, AZ 85755, USA., Leith KF; Roche Tissue Diagnostics, 1910 E. Innovation Park Drive, Tucson, AZ 85755, USA., Burgess DL; Roche Sequencing Solutions, Madison, 500 S. Rosa Road, Madison, WI 53719, USA., Watkins TBK; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK., Lim E; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK., Birkbak NJ; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark., Lamy P; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark., Nordentoft I; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark., Dyrskjøt L; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark., Pickering L; Renal and Skin Units, The Royal Marsden Hospital, London SW3 6JJ, UK., Hazell S; Histopathology Department, Royal Marsden NHS Foundation Trust, London and Sutton, UK., Jamal-Hanjani M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK; Department of Medical Oncology, University College London Hospitals, London, UK., Larkin J; Renal and Skin Units, The Royal Marsden Hospital, London SW3 6JJ, UK., Swanton C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK; Department of Medical Oncology, University College London Hospitals, London, UK. Electronic address: charles.swanton@crick.ac.uk., Alexander NR; Roche Tissue Diagnostics, 1910 E. Innovation Park Drive, Tucson, AZ 85755, USA. Electronic address: nelson.alexander@roche.com., Turajlic S; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK; Renal and Skin Units, The Royal Marsden Hospital, London SW3 6JJ, UK. Electronic address: samra.turajlic@crick.ac.uk.
Publikováno v:
Cell reports [Cell Rep] 2020 May 05; Vol. 31 (5), pp. 107550.
Autor:
Muranen T; Department of Cell Biology and Ludwig Center at Harvard, Harvard Medical School, Boston, Massachusetts., Selfors LM; Department of Cell Biology and Ludwig Center at Harvard, Harvard Medical School, Boston, Massachusetts., Hwang J; Department of Cell Biology and Ludwig Center at Harvard, Harvard Medical School, Boston, Massachusetts., Gallegos LL; Department of Cell Biology and Ludwig Center at Harvard, Harvard Medical School, Boston, Massachusetts., Coloff JL; Department of Cell Biology and Ludwig Center at Harvard, Harvard Medical School, Boston, Massachusetts., Thoreen CC; Department of Biology, Whitehead Institute for Biomedical Research and Massachusetts Institute of Technology, Cambridge, Massachusetts.; Department of Biology, Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, Massachusetts.; Koch Institute for Integrative Cancer Research, Cambridge, Massachusetts.; Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, Massachusetts., Kang SA; Department of Biology, Whitehead Institute for Biomedical Research and Massachusetts Institute of Technology, Cambridge, Massachusetts.; Department of Biology, Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, Massachusetts.; Koch Institute for Integrative Cancer Research, Cambridge, Massachusetts.; Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, Massachusetts., Sabatini DM; Department of Biology, Whitehead Institute for Biomedical Research and Massachusetts Institute of Technology, Cambridge, Massachusetts.; Department of Biology, Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, Massachusetts.; Koch Institute for Integrative Cancer Research, Cambridge, Massachusetts.; Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, Massachusetts., Mills GB; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Brugge JS; Department of Cell Biology and Ludwig Center at Harvard, Harvard Medical School, Boston, Massachusetts. joan_brugge@hms.harvard.edu.
Publikováno v:
Cancer research [Cancer Res] 2016 Dec 15; Vol. 76 (24), pp. 7168-7180. Date of Electronic Publication: 2016 Oct 20.
Autor:
Gallegos LL; Cell Biology, Harvard Med School, Boston, MA, USA., Ng MR; Cell Biology, Harvard Med School, Boston, MA, USA., Sowa ME; Cell Biology, Harvard Med School, Boston, MA, USA., Selfors LM; Cell Biology, Harvard Med School, Boston, MA, USA., White A; Cell Biology, Harvard Med School, Boston, MA, USA., Zervantonakis IK; Cell Biology, Harvard Med School, Boston, MA, USA., Singh P; Cell Biology, Harvard Med School, Boston, MA, USA., Dhakal S; Cell Biology, Harvard Med School, Boston, MA, USA., Harper JW; Cell Biology, Harvard Med School, Boston, MA, USA., Brugge JS; Cell Biology, Harvard Med School, Boston, MA, USA.
Publikováno v:
Scientific reports [Sci Rep] 2016 Jun 03; Vol. 6, pp. 27114. Date of Electronic Publication: 2016 Jun 03.
Autor:
Antal CE; Department of Pharmacology, University of California at San Diego, La Jolla, CA 92093, USA; Biomedical Sciences Graduate Program, University of California at San Diego, La Jolla, CA 92093, USA., Hudson AM; Signalling Networks in Cancer Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester M20 4BX, UK., Kang E; Department of Pharmacology, University of California at San Diego, La Jolla, CA 92093, USA., Zanca C; Ludwig Institute for Cancer Research, University of California at San Diego, La Jolla, CA 92093, USA., Wirth C; Applied Computational Biology and Bioinformatics Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester M20 4BX, UK., Stephenson NL; Signalling Networks in Cancer Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester M20 4BX, UK., Trotter EW; Signalling Networks in Cancer Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester M20 4BX, UK., Gallegos LL; Department of Pharmacology, University of California at San Diego, La Jolla, CA 92093, USA; Biomedical Sciences Graduate Program, University of California at San Diego, La Jolla, CA 92093, USA., Miller CJ; Applied Computational Biology and Bioinformatics Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester M20 4BX, UK., Furnari FB; Ludwig Institute for Cancer Research, University of California at San Diego, La Jolla, CA 92093, USA., Hunter T; The Salk Institute, La Jolla, CA 92037, USA., Brognard J; Signalling Networks in Cancer Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester M20 4BX, UK. Electronic address: john.brognard@cruk.manchester.ac.uk., Newton AC; Department of Pharmacology, University of California at San Diego, La Jolla, CA 92093, USA. Electronic address: anewton@ucsd.edu.
Publikováno v:
Cell [Cell] 2015 Jan 29; Vol. 160 (3), pp. 489-502. Date of Electronic Publication: 2015 Jan 22.
Autor:
Gallegos LL; Department of Cell Biology, Ludwig Center at Harvard, Boston, MA 02115, USA., Brugge JS; Department of Cell Biology, Ludwig Center at Harvard, Boston, MA 02115, USA. Electronic address: joan_brugge@hms.harvard.edu.
Publikováno v:
Developmental cell [Dev Cell] 2014 Jul 14; Vol. 30 (1), pp. 3-4.
Autor:
Rooney-Latham S; California Department of Food and Agriculture, Sacramento 95832., Gallegos LL; Department of Plant Pathology, University of California Davis, CA 95616., Vossen PM; University of California Cooperative Extension Sonoma County, Santa Rosa 95403., Gubler WD; Department of Plant Pathology, University of California Davis, CA 95616.
Publikováno v:
Plant disease [Plant Dis] 2013 Oct; Vol. 97 (10), pp. 1384.